Effects of the thromboxane synthetase inhibitor and receptor antagonist terbogrel in patients with primary pulmonary hypertension.

David Langleben*, Brian W. Christman, Robyn J. Barst, Virgil C. Dias, Nazzareno Galiè, Timothy W. Higenbottam, Meinhard Kneussl, Larry Korducki, Robert Naeije, Axel Riedel, Gerald Simonneau, Andrew M. Hirsch, Stuart Rich, Ivan M. Robbins, Ronald Oudiz, Michael D. McGoon, David B. Badesch, Robert D. Levy, Sanjay Mehta, Werner SeegerMarkus Solèr

*Corresponding author for this work

Research output: Contribution to journalArticlepeer-review

71 Scopus citations

Fingerprint

Dive into the research topics of 'Effects of the thromboxane synthetase inhibitor and receptor antagonist terbogrel in patients with primary pulmonary hypertension.'. Together they form a unique fingerprint.

Medicine & Life Sciences